Finance

Lists
Why is SDPC down 3,11%?
Dive Deeper
SDPC:IDX
Millennium Pharmacon Internationl Tbk PT
187,00 IDR
-3,11%
(-6,00) 1D
19-окт., 16:00:03 GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SDPC...
Open
195 IDR
High
195 IDR
Low
180 IDR
Mkt. cap
238,24 млд
Avg. vol.
725,90 миң
Volume
739,10 миң
Dividend
1,60%
Quarterly dividend
1 IDR
Ex-dividend date
2026-ж., 8-июн.
P/E ratio
5,77
52-wk high
228 IDR
52-wk low
132 IDR
EPS
32 IDR
Shares outstanding
1,27 млд
No. of employees
1 миң
Open
195 IDR
High
195 IDR
Low
180 IDR
Mkt. cap
238,24 млд
Avg. vol.
725,90 миң
Volume
739,10 миң
Dividend
1,60%
Quarterly dividend
1 IDR
Ex-dividend date
2026-ж., 8-июн.
P/E ratio
5,77
52-wk high
228 IDR
52-wk low
132 IDR
EPS
32 IDR
Shares outstanding
1,27 млд
No. of employees
1 миң
News stories
From web sources and news partners
About Millennium Pharmacon Internationl Tbk PT
CEO-
Employees1,2 миң
Founded1952
Headquarters-
SectorHealth care provider
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,06 трлн
1,11 трлн
1,02 трлн
1,11 трлн
Cost of goods sold
975,40 млд
1,00 трлн
930,34 млд
1,02 трлн
Cost of revenue
975,40 млд
1,00 трлн
930,34 млд
1,02 трлн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56,24 млд
61,14 млд
58,04 млд
62,13 млд
Operating expense
59,42 млд
71,31 млд
59,44 млд
62,19 млд
Total operating expenses
1,03 трлн
1,07 трлн
989,78 млд
1,08 трлн
Operating income
24,66 млд
33,66 млд
28,19 млд
32,27 млд
Other non operating income
-
-
-
-
EBT including unusual items
7,31 млд
21,04 млд
13,11 млд
15,00 млд
EBT excluding unusual items
7,31 млд
21,04 млд
13,11 млд
15,00 млд
Income tax expense
3,67 млд
2,95 млд
3,00 млд
5,55 млд
Effective tax rate
50,18%
14,05%
22,91%
36,97%
Other operating expenses
3,18 млд
10,17 млд
1,40 млд
61,09 млн
Net income
3,64 млд
18,08 млд
10,10 млд
9,46 млд
Net profit margin
0,34%
1,63%
0,99%
0,85%
Earnings per share
-
-
-
-
Interest and investment income
41,47 млн
45,33 млн
37,63 млн
59,17 млн
Interest expense
-17,40 млд
-12,67 млд
-15,12 млд
-17,32 млд
Net interest expenses
-17,36 млд
-12,63 млд
-15,09 млд
-17,26 млд
Depreciation and amortization charges
-
-
-
-
EBITDA
27,16 млд
36,39 млд
29,93 млд
33,89 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору